Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa

BACKGROUND: GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative are working in partnership to develop a malaria vaccine to protect infants and children living in malaria endemic regions of sub-Saharan Africa, which can be delivered through the Expanded Programme on Immunization. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Leach, Amanda, Vekemans, Johan, Lievens, Marc, Ofori-Anyinam, Opokua, Cahill, Conor, Owusu-Agyei, Seth, Abdulla, Salim, Macete, Eusebio, Njuguna, Patricia, Savarese, Barbara, Loucq, Christian, Ballou, W Ripley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199907/
https://www.ncbi.nlm.nih.gov/pubmed/21816029
http://dx.doi.org/10.1186/1475-2875-10-224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199907/
https://www.ncbi.nlm.nih.gov/pubmed/21816029
http://dx.doi.org/10.1186/1475-2875-10-224

Ejemplares similares